PCRX FY 2016 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$969M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$276M+11.0% YoY

Gross Profit

$166M60.2% margin

Operating Income

-$32M-11.6% margin

Net Income

-$38M-13.7% margin

EPS (Diluted)

$-1.02

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$9M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$391M

Total Liabilities

$172M

Stockholders' Equity

$219M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$276M	$249M	+11.0%
Gross Profit	$166M	$177M	-6.1%
Operating Income	-$32M	$9M	-438.7%
Net Income	-$38M	$2M	-2144.7%